跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,416 条关于
“Curatis Holding AG”
全部
4,416
临床试验
2,191
药物
453
机构
555
资讯
1,217
10个月前
Curatis Secures CHF 1.2 Million to Accelerate Late-Stage Corticorelin Development
去年
Curatis Secures CHF 5 Million Distribution Deal with Phoenix Labs for Pain Management and Urology Products
6个月前
Curatis Partners with Neupharma for Corticorelin Development in Japan's Brain Edema Market
去年
Curatis Advances C-PTBE-01 Toward Phase III Trial Following Positive FDA Meeting
去年
NCI and NIDDK Initiate Phase II Trial of PentixaFor for Adrenal Tumor Subtyping
去年
Curatis Reveals Corticorelin as Active Substance in C-PTBE-01 with Billion-Dollar Market Potential
去年
Fabhalta Demonstrates Sustained Efficacy in Phase III C3 Glomerulopathy Trial
去年
Formycon's Aflibercept Biosimilar, AHZANTIVE®/Baiama®, Receives Positive CHMP Opinion for EU Approval
2年前
4SC AG Receives MHRA Waiver for Resminostat in Pediatric CTCL
3年前
4SC's Resminostat Advances Towards European Market Approval for CTCL Maintenance Therapy
第 1 页,共 122 页
上一页
下一页